Compare CRON & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRON | OCSL |
|---|---|---|
| Founded | N/A | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.8M | 1.1B |
| IPO Year | 2015 | 2007 |
| Metric | CRON | OCSL |
|---|---|---|
| Price | $2.73 | $11.71 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $12.63 |
| AVG Volume (30 Days) | ★ 1.6M | 750.9K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 12.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $26.34 | N/A |
| Revenue Next Year | $15.53 | $0.31 |
| P/E Ratio | $68.38 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $1.84 | $10.63 |
| 52 Week High | $3.43 | $14.77 |
| Indicator | CRON | OCSL |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 39.26 |
| Support Level | $2.47 | $10.88 |
| Resistance Level | $2.72 | $13.19 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 39.23 | 6.11 |
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.